Applied Genetics Technologies Corporation: Funding & Investors (Sep 2026)
Applied Genetics Technologies Corporation (AGTC) is creating treatments intended to change the existences of patients with serious infections, offering desire to patients with neglected clinical requirements. With a profoundly particular group of doctors and scientists, They utilize state of the art strategies to foster medicines for patients that have illnesses brought about by broken qualities. They use quality treatment, which replaces those messed up qualities with typical utilitarian qualities, permitting a patient's own body to create proteins to treat their sickness. A solitary infusion gives durable treatment, prompting a superior personal satisfaction for patients around the world.
Applied Genetics Technologies Corporation has raised $10.0M across 1 funding round on record, the most recent a Post-IPO Equity of $10.0M announced in Jul 2022.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Applied Genetics Technologies Corporation Company Profile and Key Stats
Latest funding round on record: Jul 2022.
Applied Genetics Technologies Corporation Funding Rounds
Applied Genetics Technologies Corporation Founders and Leadership Team
No contact details are on record for this team yet.
Applied Genetics Technologies Corporation Funding Compared to Other Biotechnology Startups
Applied Genetics Technologies Corporation's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Applied Genetics Technologies Corporation in Biotechnology and Alachua
Companies Similar to Applied Genetics Technologies Corporation
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Applied Genetics Technologies Corporation Funding FAQs
What does Applied Genetics Technologies Corporation do?
Applied Genetics Technologies Corporation (AGTC) is creating treatments intended to change the existences of patients with serious infections, offering desire to patients with neglected clinical requirements. With a profoundly particular group of doctors and scientists, They utilize state of the art strategies to foster medicines for patients that have illnesses brought about by broken qualities. They use quality treatment, which replaces those messed up qualities with typical utilitarian qualities, permitting a patient's own body to create proteins to treat their sickness. A solitary infusion gives durable treatment, prompting a superior personal satisfaction for patients around the world.
How much funding has Applied Genetics Technologies Corporation raised?
Applied Genetics Technologies Corporation has raised $10.0M across 1 round on record. The most recent is a Post-IPO Equity of $10.0M announced in Jul 2022.
When did Applied Genetics Technologies Corporation last raise funding?
Applied Genetics Technologies Corporation's most recent funding round on record is a Post-IPO Equity of $10.0M, announced in Jul 2022.
Who founded Applied Genetics Technologies Corporation?
FundedIQ lists Terence Flotte (Founder) at Applied Genetics Technologies Corporation.
Where is Applied Genetics Technologies Corporation headquartered?
Applied Genetics Technologies Corporation is based in Alachua, Florida, United States.
How many employees does Applied Genetics Technologies Corporation have?
Applied Genetics Technologies Corporation is in the 11-50 employee band.
How does Applied Genetics Technologies Corporation's funding compare to other Biotechnology startups?
Applied Genetics Technologies Corporation's latest round of $10.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Applied Genetics Technologies Corporation Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Applied Genetics Technologies Corporation is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.